Is uracil enough for effective pre-emptive DPD testing?

Heersche, Niels; Matic, Maja; Mathijssen, Ron H J; Coenen, Marieke J H; van Schaik, Ron H N

Heersche, Niels; Matic, Maja; Mathijssen, Ron H J; Coenen, Marieke J H; van Schaik, Ron H N.

Afiliación

Heersche N; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Matic M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mathijssen RHJ; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Coenen MJH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.

Clin Chem Lab Med ; 2024 Jul 19.

Article en En | MEDLINE | ID: mdl-39022806

Palabras clave

DPYD; dihydrouracil; fluoropyrimidines; genotyping; uracil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google